- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Bush pushes for transparency
Washington, D.C.–An Executive Order signed by President Bush late last month will promote federally led efforts to implement more transparent and high-quality healthcare.
WASHINGTON, D.C.–An Executive Order signed by President Bush late last month will promote federally led efforts to implement more transparent and high-quality healthcare.
The Department of Health & Human Services (HHS), the Defense Department, the Veterans Affairs Dept. and the Federal Employees Health Benefit Program reportedly will be required to compile information about the quality and cost of care they pay for and share that information with their customers and each other.
The Order directs the agencies to: use information systems that "talk" to each other; enact programs that measure quality of care and develop those measures with the private sector and other government agencies; offer transparency of pricing information; and identify practices that promote quality and efficiency of care.
Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024
April 15th 2024Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024.
Read More
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
